A 58-year-old man from Delhi presents to the emergency department with a 5-day history of fever, cough, and dyspnea. His oxygen saturation is 88% on room air. Chest X-ray shows bilateral ground-glass opacities. RT-PCR for SARS-CoV-2 is positive. ABG shows pH 7.32, PaCO₂ 48 mmHg, PaO₂ 62 mmHg, HCO₃⁻ 24 mEq/L. What is the most appropriate immediate next step in management?

Explanation

## Clinical Assessment This patient has **moderate-to-severe COVID-19** with hypoxemia (PaO₂ 62 mmHg, SpO₂ 88%) and bilateral infiltrates on imaging, meeting criteria for respiratory involvement requiring hospitalization and oxygen therapy. ### Severity Classification | Feature | Mild | Moderate | Severe | |---------|------|----------|--------| | SpO₂ on RA | ≥94% | 90–93% | <90% | | Respiratory rate | <30 | 30–40 | >40 or RR <6 | | Imaging | Normal/minimal | Bilateral infiltrates | Extensive infiltrates | | PaO₂/FiO₂ | >300 | 200–300 | <200 | This patient falls into the **moderate-to-severe category** (SpO₂ 88%, bilateral ground-glass opacities, PaO₂ 62 mmHg). ## Management Algorithm ```mermaid flowchart TD A[COVID-19 confirmed]:::outcome --> B{SpO₂ on RA?}:::decision B -->|≥94%| C[Mild: Home isolation + supportive care]:::action B -->|90-93%| D[Moderate: Hospitalize + O₂ + antivirals]:::action B -->|<90%| E[Severe: HDU/ICU admission]:::action D --> F[Start remdesivir if <10 days symptoms]:::action E --> F F --> G[Add dexamethasone 6mg daily × 10 days]:::action G --> H[Monitor SpO₂, ABG, inflammatory markers]:::action ``` ## Key Management Steps **Key Point:** Patients with SpO₂ <90% or PaO₂ <60 mmHg require **immediate oxygen supplementation** targeting SpO₂ 90–95% (avoid hyperoxia, which increases mortality). **High-Yield:** The WHO/ICMR guidelines recommend: 1. **Oxygen therapy** (nasal cannula, high-flow nasal cannula, or non-invasive ventilation as needed) 2. **Remdesivir** — nucleotide analog inhibitor of viral RNA polymerase; reduces time to recovery if started within 10 days of symptom onset [cite:WHO COVID-19 Therapeutics 2023] 3. **Dexamethasone** — 6 mg once daily for up to 10 days; reduces mortality in patients requiring supplemental oxygen **Clinical Pearl:** Do NOT intubate immediately unless there is acute decompensation, airway compromise, or failure of non-invasive support. Most moderate-to-severe cases respond to high-flow oxygen + medical therapy. ## Why This Answer Is Correct The patient requires: - **Immediate oxygen** to restore PaO₂ >60 mmHg and SpO₂ ≥94% - **HDU/ICU-level care** due to respiratory compromise - **Antiviral therapy** (remdesivir) — evidence of reduced mortality and shorter recovery time - **Corticosteroid** (dexamethasone) — reduces inflammation and mortality in hypoxemic patients All four interventions are guideline-concordant for moderate-to-severe COVID-19.